Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

A 29-mRNA Host Response Test from Blood Accurately Distinguishes Bacterial and Viral Infections Among Emergency Department Patients

Asimina Safarika, James W. Wacker, Konstantinos Katsaros, Nicky Solomonidi, George Giannikopoulos, Antigone Kostaki, Ioannis M. Koutelidakis, Sabrina M. Coyle, Henry K. Cheng, Oliver Liesenfeld, Timothy E. Sweeney, Evangelos J. Giamarellos-Bourboulis
doi: https://doi.org/10.1101/2020.12.01.20242321
Asimina Safarika
14th Department of Internal Medicine, National and Kapodistrian University of Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James W. Wacker
2Inflammatix Inc, Clinical Affairs, Burlingame, CA, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Konstantinos Katsaros
3Department of Surgery, Nafplion General Hospital, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicky Solomonidi
14th Department of Internal Medicine, National and Kapodistrian University of Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
George Giannikopoulos
4Department of Internal Medicine, Syros General Hospital, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Antigone Kostaki
14th Department of Internal Medicine, National and Kapodistrian University of Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ioannis M. Koutelidakis
5nd, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sabrina M. Coyle
2Inflammatix Inc, Clinical Affairs, Burlingame, CA, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Henry K. Cheng
2Inflammatix Inc, Clinical Affairs, Burlingame, CA, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Oliver Liesenfeld
2Inflammatix Inc, Clinical Affairs, Burlingame, CA, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Timothy E. Sweeney
2Inflammatix Inc, Clinical Affairs, Burlingame, CA, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Evangelos J. Giamarellos-Bourboulis
14th Department of Internal Medicine, National and Kapodistrian University of Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: egiamarel@med.uoa.gr
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Study design Whether or not to administer antibiotics is a common and challenging clinical decision in patients with suspected infections presenting to the emergency department (ED). We prospectively validate InSep, a 29-mRNA blood-based host response test for the prediction of bacterial and viral infections.

Methods The PROMPT trial is a prospective, non-interventional, multi-center randomized, controlled clinical trial that enrolled 397 adult patients presenting to the ED with signs of acute infection and at least one vital sign change. The infection status was adjudicated using chart review (including a syndromic molecular respiratory panel, procalcitonin and C-reactive protein) by three infectious disease physicians blinded to InSep results. InSep (version BVN-2) was performed using PAXgene Blood RNA processed and quantified on NanoString nCounter SPRINT. InSep results (likelihood of bacterial and viral infection) were compared to the adjudicated infection status.

Results Subject mean age was 64 years, comorbidities were significant for diabetes (17.1%), chronic obstructive pulmonary disease (13.6%), and severe neurological disease (6.8%); 16.9% of subjects were immunocompromised. Infections were adjudicated as bacterial (14.1%), viral (11.3%) and noninfected (0.25%): 74.1% of subjects were adjudicated as indeterminate. InSep distinguished bacterial vs. viral/noninfected patients and viral vs. bacterial/noninfected patients using consensus adjudication with AUROCs of 0.94 (95% CI 0.90-0.99) and 0.90 (95% CI 0.83-0.96), respectively. AUROCs for bacterial vs. viral/noninfected patients were 0.88 (95%CI 0.79-0.96) for PCT, 0.80 (95% CI 0.72-89) for CRP and 0.78 (95% CI 0.69-0.87) for white blood cell counts (of note, the latter biomarkers were provided as part of clinical adjudication). To enable clinical actionability, InSep incorporates score cutoffs to allocate patients into interpretation bands. The Very Likely (rule in) InSep bacterial band showed a specificity of 98% compared to 94% for the corresponding PCT band (>0.5 ug/L); the Very Unlikely (rule-out) band showed a sensitivity of 95% for InSep compared to 86% for PCT. For the detection of viral infections, InSep demonstrated a specificity of 93% for the Very Likely band (rule in) and a sensitivity of 96% for the Very Unlikely band (rule out).

Conclusion InSep demonstrated high accuracy for predicting the presence of both bacterial and viral infections in ED patients with suspected acute infections or suspected sepsis. When translated into a rapid, point-of-care test, InSep will provide ED physicians with actionable results supporting early informed treatment decisions to improve patient outcomes while upholding antimicrobial stewardship.

Take-home message InSep host response test is a point-of-care test providing with accuracy the likelihood for bacterial or viral infection for patients admitted at the emergencies InSep provided information on the likelihood of bacterial co-infection among patients with COVID-19.

Competing Interest Statement

James W. Wacker, Sabrina M. Coyle, Henry K. Cheng, Oliver Liesenfeld, and Timothy E. Sweeney are employees of, and shareholders in Inflammatix. The other authors have no conflicts of interest to declare. The study was funded by Inflammatix. E.J. Giamarellos-Bourboulis has received honoraria from Abbott CH, Angelini Italy, InflaRx GmbH, MSD Greece, XBiotech Inc., and BRAHMS GmbH (Thermo Fisher Scientific); independent educational grants from AbbVie Inc, Abbott CH, Astellas Pharma Europe, AxisShield, bioMerieux Inc, Novartis, InflaRx GmbH, and XBiotech Inc; and funding from the FrameWork 7 program HemoSpec (granted to the National and Kapodistrian University of Athens), the Horizon2020 Marie-Curie Project European Sepsis Academy (granted to the National and Kapodistrian University of Athens), and the Horizon 2020 European Grant ImmunoSep (granted to the Hellenic Institute for the Study of Sepsis).

Clinical Trial

NCT 03295825

Funding Statement

The study was funded by Inflammatix Inc

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The PROMPT study was conducted under the approvals EBD2392/16.05.2017 of ATTIKON University General Hospital; 7/26.05.2017 of the General Hospital of Sparti; 1/20.07.2017 of the General Hospital of Syros; 8/12.07.2017 of the General Hospital of Halkida; 42550/20.10.2017 of the General Hospital of Argos; and 4/31.05.2017 of G. Gennimatas General Hospital of Thessaloniki

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data are available upon request to egiamarel@med.uoa.gr

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted December 04, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
A 29-mRNA Host Response Test from Blood Accurately Distinguishes Bacterial and Viral Infections Among Emergency Department Patients
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
A 29-mRNA Host Response Test from Blood Accurately Distinguishes Bacterial and Viral Infections Among Emergency Department Patients
Asimina Safarika, James W. Wacker, Konstantinos Katsaros, Nicky Solomonidi, George Giannikopoulos, Antigone Kostaki, Ioannis M. Koutelidakis, Sabrina M. Coyle, Henry K. Cheng, Oliver Liesenfeld, Timothy E. Sweeney, Evangelos J. Giamarellos-Bourboulis
medRxiv 2020.12.01.20242321; doi: https://doi.org/10.1101/2020.12.01.20242321
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
A 29-mRNA Host Response Test from Blood Accurately Distinguishes Bacterial and Viral Infections Among Emergency Department Patients
Asimina Safarika, James W. Wacker, Konstantinos Katsaros, Nicky Solomonidi, George Giannikopoulos, Antigone Kostaki, Ioannis M. Koutelidakis, Sabrina M. Coyle, Henry K. Cheng, Oliver Liesenfeld, Timothy E. Sweeney, Evangelos J. Giamarellos-Bourboulis
medRxiv 2020.12.01.20242321; doi: https://doi.org/10.1101/2020.12.01.20242321

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Emergency Medicine
Subject Areas
All Articles
  • Addiction Medicine (174)
  • Allergy and Immunology (421)
  • Anesthesia (97)
  • Cardiovascular Medicine (901)
  • Dentistry and Oral Medicine (170)
  • Dermatology (102)
  • Emergency Medicine (257)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (407)
  • Epidemiology (8789)
  • Forensic Medicine (4)
  • Gastroenterology (405)
  • Genetic and Genomic Medicine (1863)
  • Geriatric Medicine (179)
  • Health Economics (388)
  • Health Informatics (1292)
  • Health Policy (644)
  • Health Systems and Quality Improvement (492)
  • Hematology (207)
  • HIV/AIDS (394)
  • Infectious Diseases (except HIV/AIDS) (10565)
  • Intensive Care and Critical Care Medicine (564)
  • Medical Education (193)
  • Medical Ethics (52)
  • Nephrology (218)
  • Neurology (1756)
  • Nursing (103)
  • Nutrition (266)
  • Obstetrics and Gynecology (343)
  • Occupational and Environmental Health (461)
  • Oncology (965)
  • Ophthalmology (283)
  • Orthopedics (107)
  • Otolaryngology (177)
  • Pain Medicine (118)
  • Palliative Medicine (43)
  • Pathology (264)
  • Pediatrics (557)
  • Pharmacology and Therapeutics (265)
  • Primary Care Research (219)
  • Psychiatry and Clinical Psychology (1845)
  • Public and Global Health (3986)
  • Radiology and Imaging (655)
  • Rehabilitation Medicine and Physical Therapy (344)
  • Respiratory Medicine (535)
  • Rheumatology (215)
  • Sexual and Reproductive Health (178)
  • Sports Medicine (166)
  • Surgery (197)
  • Toxicology (37)
  • Transplantation (106)
  • Urology (80)